In Person

EU Pharmaceutical Law Forum 2022

May 17 – 19, 2022
Steigenberger Wiltcher's – Av. Louise 71, 1050
Event details
May 17 – 19, 2022
12:00 am
Steigenberger Wiltcher's – Av. Louise 71, 1050
Bruxelles, Belgium

Event summary

The EU Pharmaceutical Law Forum brings together legal experts from The EU Commission, EMA, Competition Authorities, EDPS, leading in-house counsel and private practice from across Europe.
   


Featured agenda item

Implications of the EU Clinical Trial Regulations (EU CTR) and Clinical Trials Information System (CTIS)
Wednesday, May 18 – 2:10 pm CET 
Cooley partner 
Elisabethann Wright is a featured speaker.

Topics include

  • Legal considerations for EU CTR for the (bio) pharmaceutical sector
  • Practical and strategic consequences of CTIS on data collation, management and the publication of clinical trial dossiers
  • Managing the disclosure of confidential and commercially sensitive data: examining the legal considerations

Event details and registration

For more information, email Alexandra Chin-Sukhdeo.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.